Jay Patel

Jay Patel


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Hearts
Verified
Journal Article
Open access
PDF file
IPIssa Pour-Ghaz
Issa Pour-Ghaz
SKSharif Kayali
Sharif Kayali
IAIman Abutineh
Iman Abutineh
JPJay Patel
Jay Patel
SRSherif Roman
Sherif Roman
NYNeeraja Yedlapati
Neeraja Yedlapati
Sarcoidosis is a chronic multi-system disorder with an unknown etiology that can affect the cardiac tissue, resulting in Cardiac Sarcoidosis (CS). The majority of these CS cases are clinically silent, and when there are symptoms, the symptoms are vague and can have a lot in common with other common cardiac diseases. These symptoms can range from arrhythmias to heart failure. If CS goes undetected, it can lead to detrimental outcomes for patients. Diagnosis depends on timely utilization of imaging modalities and non-invasive testing, while in some cases, it does necessitate biopsy. Early diagnosis and treatment with immunosuppressive agents are crucial, and it is essential that follow-up testing be performed to ensure resolution and remission. This manuscript provides an in-depth review of CS and the current literature regarding CS diagnosis and treatment.

7 August 2021 in Journal of the National Medical Association
Verified
Journal Article
Closed access
JPJay Patel
Jay Patel
MHMatthew Haltom
Matthew Haltom
CJChristopher Jackson
Christopher Jackson

Verified
Journal Article
Open access
PDF file
ABAnandbir Singh Bath
Anandbir Singh Bath
OAOguz Akbilgic
Oguz Akbilgic
DWDavid Wilbanks
David Wilbanks
JPJay Patel
Jay Patel
MWMorgan Wallen
Morgan Wallen
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies
Background: Barth syndrome (BTHS) is a rare X-linked genetic disease that affects multiple systems and leads to complex clinical manifestations. Although a considerable amount of research has focused on the physical aspects of the disease, less has focused on the psychosocial impact and quality of life (QoL) in BTHS. Methods: The current study investigated caregiver- (n = 10) and self-reported (n = 16) psychological well-being and QoL in a cohort of BTHS-affected patients and families. Participants completed the depression and anxiety components of the Patient-Reported Outcomes Information System (PROMIS) Short Form 8A and Health-related quality of life (HRQoL) surveys at enrollment and again during a follow-up period ranging from 6 to 36 months after baseline. Results: Quality of life changed significantly over time and the various domains with some improvement and some decline. Among the available caregiver-patient dyad data, there was a trend toward discordance between caregiver and self-reported outcomes. Most notably, patients reported improvement in HRQoL, while caregivers reported declines. This suggests that there may be differences in perceived quality of life between the patients and parents, though our study is limited by small sample size. Conclusion: Our study provides valuable insights into the impacts of psychosocial and mental health aspects of BTHS. Implications of these findings include incorporating longitudinal assessment of QoL and screening for psychological symptoms in BTHS care to identify interventions that may drastically impact health status and the course of the disease.